SCHEMBL16795809

SCHEMBL16795809

CCOC(=O)C(C(=O)OC(C)(C)C)(c1ccccc1)C(F)F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.42
MMP8 P22894 1/20 0.41
POLB P06746 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 4/20 0.39
THRB P10828 1/20 0.39
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38
ALDH1A1 P00352 2/20 0.38
RECQL P46063 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
CACNA1G O43497 1/20 0.38
AAK1 Q2M2I8 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28882448 0.91 PIN1 (0.49) PIN1MMP8POLBNPSR1SMN1; SMN2
SCHEMBL10723170 0.86 CYP3A4 (0.48) SMN1; SMN2MAPTCYP2C19ALDH1A1GAA
SCHEMBL10727675 0.86 ALDH1A1 (0.44) POLBNPSR1SMN1; SMN2MAPTTHRB
SCHEMBL10724853 0.85 ALDH1A1 (0.43) MAPTALDH1A1RECQLCACNA1GGAA
SCHEMBL10724757 0.85 GAA (0.38) PIN1GAA
SCHEMBL10725042 0.84 ALDH1A1 (0.41) SMN1; SMN2MAPTALDH1A1CACNA1G
SCHEMBL16795719 0.83 PIN1 (0.37) PIN1MMP8POLBNPSR1SMN1; SMN2
SCHEMBL10724756 0.81 MAPT (0.40) PIN1MMP8POLBMAPTALDH1A1
SCHEMBL16732173 0.81 PIN1 (0.50) PIN1MMP8POLBNPSR1SMN1; SMN2
SCHEMBL10722478 0.80 L3MBTL1 (0.43) POLBSMN1; SMN2MAPTCYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087094-A1 NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES SEMMELWEIS EGYETEM (HU) 2015-06-18 WO disclosed